A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...
Okay. Thank you, everyone, for joining us today for our LP-184 clinical trial results webinar. We'll be talking in depth today with some of our Lantern's team and also with our collaborator and ...
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations This was a phase II multicenter trial in which refractory solid ...
New research sheds light on how cells repair damaged DNA. For the first time, the team has mapped the activity of repair proteins in individual human cells. The study demonstrates how these proteins ...
A new fluorescent sensor is giving scientists an unprecedented view of how cells respond to DNA damage, capturing the repair process as it unfolds in real time. The tool, developed at Utrecht ...
Morning Overview on MSN
Study: Inflammation overwhelms DNA repair in some neurons in multiple sclerosis
Researchers have identified a specific class of brain neurons that dies during multiple sclerosis because inflammation ...
Applied DNA Sciences (APDN) announced that the State Institute for Drug Control of the Czech Republic approved an application for a Phase I clinical trial of an investigational CD123-specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results